All News about Alvotech - Ordinary Shares![]()
Alvotech Secures Financing Facilities of Approximately $136 Million
November 16, 2022
From Alvotech
Via GlobeNewswire
![]()
Alvotech Reports Financial Results for First Nine Months of 2022 And Provides Business Update
November 16, 2022
From Alvotech
Via GlobeNewswire
![]()
Alvotech Announces Australian Marketing Authorization for AVT02, a Biosimilar to Humira®
November 14, 2022
From Alvotech
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]()
Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November
October 26, 2022
From Alvotech
Via GlobeNewswire
![]() ![]() ![]()
Alvotech Appoints Sarah Tanksley as Chief Quality Officer
October 11, 2022
From Alvotech
Via GlobeNewswire
![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
September 07, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|